GSTM1 and fibrosis: Notably, two previous studies evaluating the association of GSTM1 and GSTT1 polymorphisms with progression of liver disease in Egyptian [23] and Taiwanese [25] patients with chronic HCV showed considerably increased risk of advanced fibrosis in individuals with combined GSTM1/GSTT1 double-null genotype.